VPIM
NKTR icon

Vanguard Personalized Indexing Management’s Nektar Therapeutics NKTR Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$265K Buy
+3,685
New +$210K ﹤0.01% 1675
2025
Q4 		– Sell
-3,911
Closed -$223K – 2040
2025
Q3 		$223K Buy
+3,911
New +$129K ﹤0.01% 1641
2025
Q2 		– Sell
-2,458
Closed -$25.1K – 2005
2025
Q1 		$25.1K Buy
2,458
+1,335
+119% +$17.4K ﹤0.01% 1750
2024
Q4 		$15.7K Buy
1,123
+261
+30% +$4.6K ﹤0.01% 1783
2024
Q3 		$16.8K Buy
862
+6
+0.7% +$114 ﹤0.01% 1741
2024
Q2 		$15.9K Buy
856
+65
+8% +$1.37K ﹤0.01% 1671
2024
Q1 		$11.1K Buy
+791
New +$8.28K ﹤0.01% 1619
2023
Q4 		– Sell
-2,572
Closed -$23K – 1611
2023
Q3 		$23K Buy
+2,572
New +$24.8K ﹤0.01% 1449

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Personalized Indexing Management's NKTR Position: Q1 2026 in Review

Vanguard Personalized Indexing Management opened a new position in Nektar Therapeutics (NKTR) in Q1 2026: 3,685 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #1675 among its holdings. This is a return to the name: Vanguard Personalized Indexing Management previously reported a position in NKTR as recently as Q3 2025.

Vanguard Personalized Indexing Management first reported a position in NKTR in Q3 2023 and has held it in 8 quarters since. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Vanguard Personalized Indexing Management held 3,685 shares of Nektar Therapeutics worth $265K as of Q1 2026.
  • Nektar Therapeutics was a new Vanguard Personalized Indexing Management position in Q1 2026.
  • Nektar Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1675 holding.
  • Vanguard Personalized Indexing Management first reported a position in Nektar Therapeutics in Q3 2023 and has held it in 8 quarters since.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.